Laserfiche WebLink
FINAL AGREEMENT 3.25.22 <br /> EXHIBIT E <br /> List of Opioid Remediation Uses <br /> Schedule A <br /> Core Strategies <br /> States and Qualifying Block Grantees shall choose from among the abatement strategies listed in <br /> Schedule B. However,priority shall be given to the following core abatement strategies ("Core <br /> Strategies").14 <br /> A. NALOXONE OR OTHER FDA-APPROVED DRUG TO <br /> REVERSE OPIOID OVERDOSES <br /> 1. Expand training for first responders, schools, community <br /> support groups and families; and <br /> 2. Increase distribution to individuals who are uninsured or <br /> whose insurance does not cover the needed service. <br /> B. MEDICATION-ASSISTED TREATMENT("MAT") <br /> DISTRIBUTION AND OTHER OPIOID-RELATED <br /> TREATMENT <br /> 1. Increase distribution of MAT to individuals who are <br /> uninsured or whose insurance does not cover the needed <br /> service; <br /> 2. Provide education to school-based and youth-focused <br /> programs that discourage or prevent misuse; <br /> 3. Provide MAT education and awareness training to <br /> healthcare providers, EMTs, law enforcement,and other <br /> first responders; and <br /> 4. Provide treatment and recovery support services such as <br /> residential and inpatient treatment, intensive outpatient <br /> treatment, outpatient therapy or counseling, and recovery <br /> housing that allow or integrate medication and with other <br /> support services. <br /> 14 As used in this Schedule A,words like"expand,""fund,""provide"or the like shall not indicate a preference for <br /> new or existing programs. <br /> E-1 <br />